Pages that link to "Q28186033"
Jump to navigation
Jump to search
The following pages link to Potential for proteasome inhibition in the treatment of cancer (Q28186033):
Displaying 50 items.
- The proteosome inhibitor MG132 attenuates retinoic acid receptor trans-activation and enhances trans-repression of nuclear factor kappaB. Potential relevance to chemo-preventive interventions with retinoids (Q24792397) (← links)
- Proteasome inhibitors: their effects on arachidonic acid release from cells in culture and arachidonic acid metabolism in rat liver cells (Q24801210) (← links)
- KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism (Q27853300) (← links)
- The ubiquitin-proteasome system (Q28305844) (← links)
- Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome. (Q30653697) (← links)
- Assays for high-throughput screening of E2 AND E3 ubiquitin ligases (Q33228958) (← links)
- Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia (Q33371900) (← links)
- Bortezomib-induced congestive cardiac failure in a patient with multiple myeloma (Q33397376) (← links)
- Bioactive 5,6-dihydro-alpha-pyrone derivatives from Hyptis brevipes (Q33440790) (← links)
- Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells (Q33622430) (← links)
- Dynamics and evolution of β-catenin-dependent Wnt signaling revealed through massively parallel clonogenic screening. (Q33903540) (← links)
- Proteasome inhibition and its therapeutic potential in multiple myeloma (Q34343036) (← links)
- Cellular and computational studies of proteasome inhibition and apoptosis induction in human cancer cells by amino acid Schiff base-copper complexes. (Q34473291) (← links)
- Biodistribution and Efficacy Studies of the Proteasome Inhibitor BSc2118 in a Mouse Melanoma Model (Q34478543) (← links)
- Recent advances in proteasome inhibitor discovery (Q34645067) (← links)
- NOB1 is essential for the survival of RKO colorectal cancer cells (Q34985999) (← links)
- Gold(III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia. (Q35083349) (← links)
- Proteasome inhibitor patents (2010 - present). (Q35085938) (← links)
- Synthesis and anti-cancer activities of a water soluble gold(III) porphyrin (Q35530076) (← links)
- Mixed ligand copper(II) dicarboxylate complexes: the role of co-ligand hydrophobicity in DNA binding, double-strand DNA cleavage, protein binding and cytotoxicity (Q35625019) (← links)
- An introduction to the molecular mechanisms of apoptosis (Q35700262) (← links)
- Bortezomib and its role in the management of patients with multiple myeloma (Q35728630) (← links)
- New molecular targets for treatment of lymphoma (Q35855032) (← links)
- The ubiquitin system: pathogenesis of human diseases and drug targeting (Q35967532) (← links)
- Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis (Q35997166) (← links)
- The ubiquitin-proteasome system in HIV replication: potential targets for antiretroviral therapy (Q36066214) (← links)
- Classification of breast cancer patients using somatic mutation profiles and machine learning approaches. (Q36121092) (← links)
- Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting (Q36226090) (← links)
- Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies (Q36238764) (← links)
- Intracellular protein degradation: from a vague idea, through the lysosome and the ubiquitin-proteasome system, and onto human diseases and drug targeting (Nobel lecture). (Q36249157) (← links)
- Novel treatment strategies for aggressive non-Hodgkin's lymphoma (Q36429727) (← links)
- Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts (Q36465296) (← links)
- Proteasome inhibition as novel treatment strategy in leukaemia (Q36513273) (← links)
- Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies. (Q36529784) (← links)
- The ubiquitin-proteasome pathway in viral infections (Q36538328) (← links)
- Hodgkin's lymphoma: molecular targets and novel treatment strategies (Q36572545) (← links)
- From bortezomib to other inhibitors of the proteasome and beyond (Q36852277) (← links)
- 1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity. (Q36869057) (← links)
- A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells (Q36900376) (← links)
- Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo (Q36916903) (← links)
- Relationship between the methylation status of dietary flavonoids and their growth-inhibitory and apoptosis-inducing activities in human cancer cells (Q36952604) (← links)
- Intracellular Protein Degradation: From a Vague Idea through the Lysosome and the Ubiquitin-Proteasome System and onto Human Diseases and Drug Targeting (Q36999963) (← links)
- Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity (Q37148849) (← links)
- Inhibition of tumor proteasome activity by gold-dithiocarbamato complexes via both redox-dependent and -independent processes (Q37158093) (← links)
- The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy (Q37175850) (← links)
- Role of proteasomes in cellular regulation (Q37188091) (← links)
- Novel 8-hydroxylquinoline analogs induce copper-dependent proteasome inhibition and cell death in human breast cancer cells. (Q37189804) (← links)
- Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency (Q37348467) (← links)
- Efficient hydrolysis of organotrifluoroborates via silica gel and water (Q37390586) (← links)
- Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers (Q37702094) (← links)